These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 35264710)

  • 1. Transcellular propagation of fibrillar α-synuclein from enteroendocrine to neuronal cells requires cell-to-cell contact and is Rab35-dependent.
    Rodrigues PV; de Godoy JVP; Bosque BP; Amorim Neto DP; Tostes K; Palameta S; Garcia-Rosa S; Tonoli CCC; de Carvalho HF; de Castro Fonseca M
    Sci Rep; 2022 Mar; 12(1):4168. PubMed ID: 35264710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
    Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
    Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells.
    Rostami J; Jäntti M; Cui H; Rinne MK; Kukkonen JP; Falk A; Erlandsson A; Myöhänen T
    Biomed Pharmacother; 2020 Nov; 131():110788. PubMed ID: 33152946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.
    Underwood R; Gannon M; Pathak A; Kapa N; Chandra S; Klop A; Yacoubian TA
    Acta Neuropathol Commun; 2021 Jan; 9(1):13. PubMed ID: 33413679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils.
    Redmann M; Wani WY; Volpicelli-Daley L; Darley-Usmar V; Zhang J
    Redox Biol; 2017 Apr; 11():429-437. PubMed ID: 28068606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons.
    Wu Q; Takano H; Riddle DM; Trojanowski JQ; Coulter DA; Lee VM
    J Neurosci; 2019 Jun; 39(26):5080-5094. PubMed ID: 31036761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits.
    Negrini M; Tomasello G; Davidsson M; Fenyi A; Adant C; Hauser S; Espa E; Gubinelli F; Manfredsson FP; Melki R; Heuer A
    J Parkinsons Dis; 2022; 12(4):1133-1153. PubMed ID: 35213388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sortilin acts as an endocytic receptor for α-synuclein fibril.
    Ishiyama S; Hasegawa T; Sugeno N; Kobayashi J; Yoshida S; Miki Y; Wakabayashi K; Fukuda M; Kawata Y; Nakamura T; Sato K; Ezura M; Kikuchi A; Takeda A; Aoki M
    FASEB J; 2023 Jul; 37(7):e23017. PubMed ID: 37272890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.
    García-Revilla J; Boza-Serrano A; Jin Y; Vadukul DM; Soldán-Hidalgo J; Camprubí-Ferrer L; García-Cruzado M; Martinsson I; Klementieva O; Ruiz R; Aprile FA; Deierborg T; Venero JL
    Acta Neuropathol; 2023 Jul; 146(1):51-75. PubMed ID: 37202527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex.
    Boutros SW; Raber J; Unni VK
    J Parkinsons Dis; 2021; 11(3):1091-1115. PubMed ID: 34057097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo.
    Wu Q; Shaikh MA; Meymand ES; Zhang B; Luk KC; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2020 Dec; 140(6):831-849. PubMed ID: 33021680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Single Chain Fragment Variant Binding Misfolded Alpha-Synuclein Exhibits Neuroprotective and Antigen-Specific Anti-Inflammatory Properties.
    Fassler M; Benaim C; George J
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathology.
    Gerez JA; Prymaczok NC; Rockenstein E; Herrmann US; Schwarz P; Adame A; Enchev RI; Courtheoux T; Boersema PJ; Riek R; Peter M; Aguzzi A; Masliah E; Picotti P
    Sci Transl Med; 2019 Jun; 11(495):. PubMed ID: 31167929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson's Disease.
    Huang R; Gao Y; Duan Q; Zhang Q; He P; Chen J; Ma G; Wang L; Zhang Y; Nie K; Wang L
    Mol Neurobiol; 2023 Feb; 60(2):979-1003. PubMed ID: 36394710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein in gut endocrine cells and its implications for Parkinson's disease.
    Chandra R; Hiniker A; Kuo YM; Nussbaum RL; Liddle RA
    JCI Insight; 2017 Jun; 2(12):. PubMed ID: 28614796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction.
    Gentzel RC; Toolan D; Jinn S; Schachter JB; Ma L; Kahle PJ; Smith SM; Marcus JN
    Neurobiol Aging; 2021 Oct; 106():12-25. PubMed ID: 34225000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype.
    Yildirim-Balatan C; Fenyi A; Besnault P; Gomez L; Sepulveda-Diaz JE; Michel PP; Melki R; Hunot S
    J Neuroinflammation; 2024 Feb; 21(1):54. PubMed ID: 38383421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein decoy peptide protects mice against α-synuclein-induced memory loss.
    Guo Q; Kawahata I; Jia W; Wang H; Cheng A; Yabuki Y; Shioda N; Fukunaga K
    CNS Neurosci Ther; 2023 Jun; 29(6):1547-1560. PubMed ID: 36786129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
    Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.